Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
AUPH

Aurinia Pharmaceuticals (AUPH) stock: insider trades, news & valuation

Net buying
Close · Oct 9, 2026 $16.65 +2.7% on the day +43.3% over 12 months 52-week range $11.10 – $18.62

Share price and insider trades

AUPH closeInsider buyInsider sale
1012151820NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $190,427 on 2026-09-10 · Stephen P. RobertsonSold $355,946 on 2026-08-21 · Stephen P. RobertsonBought $2,619,438 on 2026-03-03 · Kevin TangBought $2,842,833 on 2026-03-02 · Kevin TangBought $3,147,756 on 2026-06-02 · Kevin TangBought $4,056,951 on 2026-05-29 · Kevin TangBought $5,250,520 on 2026-06-01 · Kevin TangBought $7,226,535 on 2026-02-27 · Kevin Tang
Bought, 12 months$25.1M
Sold, 12 months$546K
Insiders buying1
Insiders selling1

Aurinia Pharmaceuticals insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $25.1M and 1 sold $546K of AUPH stock on the open market.

AUPH insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $12.7M bought (6 trades)$12.7MQ1 2026Q2 2026: $12.5M bought (5 trades)$12.5MQ2 2026Q3 2026: $546K sold (2 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$546K2
Q2 2026$12.5M5—0
Q1 2026$12.7M6—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.8×Last 5 sessions
Insiders' paper profit+$3.4MOn all tracked purchases +13.5%

Summary

Over the past 12 months, 1 Aurinia Pharmaceuticals Inc. insider reported open-market purchases totaling $25.1M, while 1 insider reported sales totaling $546K. Among insiders with enough purchase history to measure, Kevin Tang (CEO) has the highest Insider Score at 50. 0 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 11SEC Stephen P. RobertsonGeneral Counsel Sell 11,939588,848 held (−2%) $15.95 $190K +4.4% —
Aug 25SEC Stephen P. RobertsonGeneral Counsel Sell 20,975600,787 held (−3%) $16.97 $356K -1.9% —
Jun 2SEC Kevin TangCEO Buy 343,52112,838,002 held (+3%) $15.28 $5.2M +9.0% 50
Jun 2SEC Kevin TangCEO Buy 262,68212,494,481 held (+2%) $15.31 $4.0M +8.8% 50
Jun 2SEC Kevin TangCEO Buy 206,00513,044,106 held (+2%) $15.28 $3.1M +9.0% 50
Jun 2SEC Kevin TangCEO Buy 2,29912,231,799 held (+0%) $15.35 $35K +8.5% 50
Jun 2SEC Kevin TangCEO Buy 9912,838,101 held (+0%) $15.34 $2K +8.5% 50
Mar 3SEC Kevin TangDirector Buy 300,00011,629,500 held (+3%) $13.90 $4.2M +19.8% 50
Mar 3SEC Kevin TangDirector Buy 214,83911,844,339 held (+2%) $14.12 $3.0M +17.9% 50
Mar 3SEC Kevin TangDirector Buy 184,20812,229,500 held (+2%) $14.22 $2.6M +17.1% 50
Mar 3SEC Kevin TangDirector Buy 115,79212,045,292 held (+1%) $14.21 $1.6M +17.2% 50
Mar 3SEC Kevin TangDirector Buy 83,56111,929,500 held (+1%) $14.33 $1.2M +16.2% 50
Mar 3SEC Kevin TangDirector Buy 1,60011,845,939 held (+0%) $14.38 $23K +15.8% 50

Insiders at Aurinia Pharmaceuticals Inc.

InsiderBoughtSoldLast filingScore
Kevin TangCEO $25.1M — Jun 2, 2026 50
Stephen P. RobertsonGeneral Counsel — $546K Sep 11, 2026 —

AUPH stock: common questions

Are Aurinia Pharmaceuticals Inc. insiders buying AUPH stock?

In the past 12 months, 1 insiders reported open-market purchases of AUPH worth $25.1M. The latest was CEO Kevin Tang bought $5.2M of AUPH at $15.28 — largest purchase by this insider in our records.

Are Aurinia Pharmaceuticals Inc. insiders selling AUPH stock?

1 insiders reported sales worth $546K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is AUPH's 52-week range?

Over the past year AUPH has traded between $11.10 and $18.62. It last closed at $16.65 on Oct 9, 2026.